Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
2009 OCT 12 ... hormone (iPTH) level was 144 +/- 149 pg/mL. A total of 70 patients (13.7%) had hypercalcemia defined by a corrected serum calcium >10.2 mg/dL. When the patients were classified ...
2009 OCT 12 ... after autologous transplantation for ATL. Both patients had lymphocytosis, severe hypercalcemia, and CD25+ T-cell immunophenotype on peripheral blood. In both patients, HTLV-I serology ...
2009 OCT 12 ... activity, exerting antitumor effects without producing serious side effects such as hypercalcemia. On the other hand, ED-71, which possesses a hydroxypropoxy substituent at the 2 ...
2009 NOV 23 ... marketing in the U.S. for treatment of symptomatic patients with cancer related hypercalcemia that is resistant to hydration. The Company has developed G4544, an oral formulation of ...
2009 NOV 2 ... therapy, including narrow therapeutic window and propensity for hypercalciuria and hypercalcemia, have prompted investigation into alternatives, namely PTH replacement and parathyroid ...
2009 NOV 23 ... III and V evidence supports an etiologic link between sustained lithium therapy and both hypercalcemia and hyperparathormonemia (grade C recommendation). Level V evidence supports the use of ...
2009 NOV 2 ... + dexamethasone + gefitinib). A total of 20 patients were treated. Dose-limiting hypercalcemia was observed in two out of the four patients receiving 163 mcg/week of calcitriol. Mean ...
2009 OCT 19 ... in the United States conducted a study "To report and describe a case of refractory hypercalcemia of malignancy (HCM) associated with metastatic, transitional-cell carcinoma of the left ...
2009 NOV 23 ... jaw-tumor syndrome, were strongly associated with sporadic parathyroid carcinoma. Severe hypercalcemia and its related clinical symptoms, extremely high levels of parathyroid hormone, ...
2009 OCT 12 ... 17% to 50% of patients at 1 year after renal transplantation. In 10% of these patients, hypercalcemia is also present," investigators in Madrid, Spain report. "This condition ...
2009 NOV 10 ... +/- 0.18) at 3 months, and 2.28 mmol/l (SD +/- 0.13) at 6 months. Two patients with mild hypercalcemia (2.69 mmol/l) at 3 months had normal values at 6 months. Based On our observations, a ...
2009 OCT 20 ... "The study was performed on 57 clinically stable CAPD patients with hypercalcemia. All patients were randomized to switch to 1.25 mmol/L calcium dialysate (group A) or ...
2009 OCT 12 ... could be used to treat hepatocellular carcinoma (HCC). However, the major side-effect of hypercalcemia limits its use," wrote K.C. Chiang and colleagues, Boston University, Medical ...
2009 OCT 12 ... it. After kidney transplantation (KTx), moderate to severe SHPT may persist and cause hypercalcemia and hypophosphatemia, among other deleterious effects." "The number of ...
2009 OCT 12 ... no improvement in her symptoms. Laboratory studies revealed anemia, thrombocytopenia, hypercalcemia, and acute renal failure. The patient was admitted for further evaluation. Upon ...
2009 OCT 12 ... (SHP) with vitamin D analogues is determined by their effectiveness to reverse hypercalcemia. Calcimimetics inhibit parathyroid hormone (PTH) secretion by modulating the ...
2009 OCT 12 ... a paracrine/autocrine factor originally described as the hormone responsible for hypercalcemia of malignancy. PTHrP is developmentally regulated and expressed, and it has been shown ...
2009 OCT 12 ... lymphoma/leukemia (ATL), which is invariably fatal and often associated with humoral hypercalcemia of malignancy. The transformation of infected CD4 T cells and the pathogenesis of ...
2009 NOV 2 ... on 2.5mg PTH1-34 (100 mg 5-CNAC) withdrew because of symptomatic, but unconfirmed, hypercalcemia. PTH is produced by the parathyroid glands to regulate the amount of ...
